㈜글라세움

{
  "address": "경기도 수원시",
  "ceo_name": "유상구",
  "certificate": [
    {
      "cert_number": "20170102104",
      "changes": "",
      "disclosure_date": "2017-03-15",
      "first_cert_date": "2017-03-15",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2017-03-15 ~ 2019-03-14"
    },
    {
      "cert_number": "20190102575",
      "changes": "",
      "disclosure_date": "2019-03-26",
      "first_cert_date": "2017-03-15",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2019-03-15 ~ 2021-03-14"
    },
    {
      "cert_number": "20210101772",
      "changes": "",
      "disclosure_date": "2021-02-26",
      "first_cert_date": "2017-03-15",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2021-03-15 ~ 2023-03-14"
    },
    {
      "cert_number": "20230405020015",
      "changes": "",
      "disclosure_date": "2023-04-05",
      "first_cert_date": "2017-03-15",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2023-03-15 ~ 2026-03-14"
    }
  ],
  "company_name": "㈜글라세움",
  "corp_no": "135811-*******",
  "financials": {
    "2022": {
      "capital_stock": 30866245000,
      "cost_of_sales": 0,
      "current_assets": 19490667000,
      "current_liabilities": 934271000,
      "gross_profit": 1000000000,
      "net_income": -6453232000,
      "net_income_bs": -6453232000,
      "non_current_assets": 989465000,
      "non_current_liabilities": 64164000,
      "non_operating_expenses": 125797000,
      "non_operating_income": 921405000,
      "operating_profit": -7248840000,
      "revenue": 1000000000,
      "sga_expenses": 8248840000,
      "total_assets": 20480132000,
      "total_equity": 19481697000,
      "total_liabilities": 998435000
    },
    "2023": {
      "capital_stock": 27391516000,
      "cost_of_sales": 0,
      "current_assets": 14417757000,
      "current_liabilities": 661651000,
      "gross_profit": 0,
      "net_income": -2551939000,
      "net_income_bs": -2551939000,
      "non_current_assets": 981573000,
      "non_current_liabilities": 53643000,
      "non_operating_expenses": 34346000,
      "non_operating_income": 4119558000,
      "operating_profit": -6637151000,
      "revenue": 0,
      "sga_expenses": 6637151000,
      "total_assets": 15399330000,
      "total_equity": 14684036000,
      "total_liabilities": 715294000
    },
    "2024": {
      "capital_stock": 25250541000,
      "cost_of_sales": 0,
      "current_assets": 10556361000,
      "current_liabilities": 239971000,
      "gross_profit": 0,
      "net_income": -1833774000,
      "net_income_bs": -1833774000,
      "non_current_assets": 843362000,
      "non_current_liabilities": 11229000,
      "non_operating_expenses": 12720000,
      "non_operating_income": 2640885000,
      "operating_profit": -4461939000,
      "revenue": 0,
      "sga_expenses": 4461939000,
      "total_assets": 11399723000,
      "total_equity": 11148523000,
      "total_liabilities": 251200000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "비만, 당뇨, OA, PD, NASH 등",
  "phone": "031-8002-****",
  "years": [
    2024,
    2023,
    2022
  ]
}